TABLE 2 ] .
Characteristic | ICU vs Non-ICU Hospitalization | P Value | Intermediate ICU vs Full-Service ICU Admission | P Value |
Age | ||||
65-69 y | Reference | … | … | … |
70-74 y | 0.93 (0.89-0.96) | < .001 | 1.24 (1.06-1.19) | < .001 |
75-79 y | 0.80 (0.77-0.83) | < .001 | 1.28 (1.21-1.36) | < .001 |
80-84 y | 0.67 (0.64-0.70) | < .001 | 1.47 (1.37-1.57) | < .001 |
85-89 y | 0.55 (0.51-0.58) | < .001 | 1.64 (1.50-1.79) | < .001 |
≥ 90 y | 0.42 (0.38-0.46) | < .001 | 2.14 (1.84-2.48) | < .001 |
Sex | ||||
Women | Reference | … | … | … |
Men | 1.10 (1.07-1.12) | < .001 | 0.9 (0.87-0.94) | < .001 |
Race/ethnicity | ||||
Non-Hispanic white | Reference | … | … | … |
Black | 1.22 (1.16-1.28) | < .001 | 1.04 (0.97-1.12) | .29 |
Other | 1.33 (1.26-1.41) | < .001 | 1.06 (0.98-1.25) | .14 |
Median annual income | ||||
< 15,000 USD | Reference | … | … | … |
15,000-29,000 USD | 1.47 (1.40-1.54) | < .001 | 1.55 (1.44-1.67) | < .001 |
30,000-44,990 USD | 1.36 (1.31-1.41) | < .001 | 1.72 (1.61-1.83) | < .001 |
45,000-59,990 USD | 1.48 (1.41-1.54) | < .001 | 2.02 (1.89-2.16) | < .001 |
60,000-74,990 USD | 1.48 (1.41-1.56) | < .001 | 2.04 (1.89-2.20) | < .001 |
≥ 75,000 USD | 1.50 (1.42-1.57) | < .001 | 2.05 (1.89-2.22) | < .001 |
Comorbidities | ||||
0 | Reference | … | … | … |
1 | 1.16 (1.11-1.21) | < .001 | 1.06 (0.99-1.13) | .07 |
2 | 1.27 (1.20-1.34) | < .001 | 1.08 (1.00-1.26) | .05 |
≥ 3 | 1.46 (1.38-1.54) | < .001 | 1.05 (0.96-1.13) | .29 |
Lung cancer histology | ||||
NSCLC | Reference | … | … | … |
SCLC | 0.91 (0.87-0.94) | < .001 | 1.02 (0.96-1.08) | .56 |
Other | 0.79 (0.75-0.83) | < .001 | 1.0 (0.92-1.08) | .99 |
Stage at diagnosis | ||||
Local | Reference | … | … | … |
Regional | 0.90 (0.87-0.94) | < .001 | 0.90 (0.84-0.95) | < .001 |
Distant | 0.61 (0.59-0.63) | < .001 | 0.91 (0.86-0.96) | < .001 |
Unknown | 0.74 (0.70-0.79) | < .001 | 0.81 (0.75-0.89) | < .001 |
Data are presented as adjusted OR (95% CI). See Table 1 legend for expansion of abbreviations.